Valuing Celegene’s CVR
Anyone ever look at the HBS case study? Should Tanaka buy more CVRs, hold, or sell her CVRs? Thanks!
Anyone ever look at the HBS case study? Should Tanaka buy more CVRs, hold, or sell her CVRs? Thanks!
| +137 | UBS Catastrophic Q1-Q3 26, M&A -17%, Outside Top 10 in Americas, EMEA & APAC | 37 | 1d |
| +59 | PWP acquisition by Piper cancelled | 22 | 4h |
| +29 | Evercore poaches Baird DC Defense Team | 18 | 17h |
| +28 | Houston banking Gods ? | 16 | 2d |
| +21 | Normal for lateral process to go +2 months? | 4 | 1d |
| +21 | Best Houston Banks for Culture in 2026 | 14 | 13h |
| +17 | Lack of talent in IB! | 19 | 4h |
| +17 | Internal lateral from coverage to M&A (focused on coverage) | 4 | 18h |
| +15 | How standard is weekend work in IBD? | 7 | 10m |
| +15 | Discussion Transaction Experience in Lateral Interviews | 3 | 3d |
Career Resources